Showing 1 - 11 results of 11 for search 'Michael D. Hill', query time: 0.03s
Refine Results
-
1
-
2
-
3
-
4
Comparing Early National Institutes of Health Stroke Scale Versus 90‐Day Modified Rankin Scale Outcomes in Acute Ischemic Stroke Trials: A Systematic Review and Analysis by Leon A. Rinkel, Johanna M. Ospel, Manon Kappelhof, Arshia Sehgal, Rosalie V. McDonough, Michael Tymianski, Michael D. Hill, Mayank Goyal, Aravind Ganesh
Published 2025-05-01Get full text
Article -
5
Combining Computed Tomography Perfusion and Baseline National Institutes of Health Stroke Scale to Assess the Clinical Penumbra in Ischemic Stroke by Umberto Pensato, Alexander Stebner, Salome Bosshart, Ruchir Shah, Axel Rohr, Ricardo Hanel, Michael E. Kelly, Aditya Bharatha, Michael D. Hill, Mayank Goyal, Andrew M. Demchuk, Johanna M. Ospel
Published 2025-05-01Get full text
Article -
6
Sex Differences in Outcomes After Tenecteplase for Minor Stroke: A Subanalysis of the TEMPO‐2 Trial by Amy Y. X. Yu, Shabnam Vatanpour, Aravind Ganesh, Thalia S. Field, Philip A. Barber, Philip M. C. Choi, Brian Buck, Timothy Kleinig, Carlos A. Molina, Bruce C. V. Campbell, Ramana Appireddy, Keith W. Muir, Michael D. Hill, Shelagh B. Coutts
Published 2025-05-01Get full text
Article -
7
Population Trends of New Prescriptions for Antihyperglycemics and Antihypertensives Between 2014 and 2022 by Amy Y. X. Yu, Peter C. Austin, Cynthia A. Jackevicius, Anna Chu, Jessalyn K. Holodinsky, Michael D. Hill, Noreen Kamal, Mukesh Kumar, Douglas S. Lee, Manav V. Vyas, Raed A. Joundi, Nadia A. Khan, Moira K. Kapral, Candace D. McNaughton
Published 2024-04-01Get full text
Article -
8
Incident prescriptions for common cardiovascular medications: comparison of recent versus pre-2020 medication adherence and discontinuation in three universal health care systems by Candace D. McNaughton, Peter C. Austin, Cynthia A. Jackevicius, Anna Chu, Jessalyn K. Holodinsky, Michael D. Hill, Colleen M. Norris, Mukesh Kumar, Noreen Kamal, Douglas S. Lee, Nadia Khan, Manav V. Vyas, Raed A. Joundi, Moira K. Kapral, Amy Y. X. Yu
Published 2025-02-01Get full text
Article -
9
Cognitive Assessments in Randomized Controlled Trials of Acute or Secondary Prevention Stroke Treatments 2011 to 2024: A Scoping Review by Sajeevan Sujanthan, Jesse Buchman, Aaron Herlick, Damyen Henderson‐Lee Wah, William Betzner, Alisia Southwell, Theresa Aves, Pugaliya Puveendrakumaran, Idris Fatakdawala, Vanessa Norouzi, Teruko Kishibe, Michael D. Hill, Raed A. Joundi, Ryan T. Muir, Bijoy K. Menon, Jennifer S. Rabin, Katie N. Dainty, Morgan Barense, Krista L. Lanctôt, Aravind Ganesh, Richard H. Swartz
Published 2025-08-01Get full text
Article -
10
Improving access and efficiency of acute ischemic stroke treatment across four Canadian provinces: a stepped-wedge trial by Noreen Kamal, Noreen Kamal, Noreen Kamal, Elena A. Cora, Elena A. Cora, Simone Alim, Judah Goldstein, Judah Goldstein, David Volders, David Volders, Shadi Aljendi, Heather Williams, Patrick T. Fok, Patrick T. Fok, Patrick T. Fok, Etienne van der Linde, Trish Helm-Neima, Renee Cashin, Brian Metcalfe, Brian Metcalfe, Julie Savoie, Wendy Simpkin, Cassie Chisholm, Michael D Hill, Bijoy K. Menon, Stephen Phillips, Stephen Phillips
Published 2025-08-01Get full text
Article -
11
Factors Influencing Nerinetide Effect on Clinical Outcome in Patients Without Alteplase Treatment in the ESCAPE-NA1 Trial by Mayank Goyal, Bijoy K. Menon, Johanna Ospel, Mohammed Almekhlafi, Charlotte Zerna, Raul Nogueira, Ryan McTaggart, Andrew M. Demchuk, Alexandre Y. Poppe, Brian Buck, Kathy Heard, Manish Joshi, Diogo Haussen, Shawna Cutting, Shelagh B. Coutts, Daniel Roy, Jeremy L. Rempel, Thalia S. Field, Dar Dowlatshahi, Brian van Adel, Richard Swartz, Ruchir Shah, Eric Sauvageau, Volker Puetz, Frank L. Silver, Bruce Campbell, René Chapot, Michael Tymianski, Michael D. Hill, on Behalf of the ESCAPE-NA1 Investigators
Published 2025-01-01Get full text
Article